Algert Global LLC

SEC CIK: 0001275218
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

GTHX holding history

G1 Therapeutics, Inc. in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GTHX overview All 13F holders of GTHX Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2023

Holdings of GTHX by Algert Global LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−38,470−100.0%	Sold out	Holders
Q4 2023	38,470	$117.3K	<0.1%	−29,630−43.5%	Reduced	Holders
Q3 2023	68,100	$98.1K	<0.1%	+68,100	New	Holders